{"product_id":"globalcordbloodcorp-marketing-mix","title":"Global Cord Blood Marketing Mix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGo Beyond the Snapshot—Get the Full Strategy\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eDiscover how Global Cord Blood aligns Product innovation, Pricing tiers, Place channels, and Promotion tactics to capture market share—get the full 4Ps Marketing Mix Analysis in an editable, presentation-ready format for immediate use.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eroduct\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrivate Cord Blood Stem Cell Storage\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePrivate cord blood storage collects and cryogenically preserves a newborn’s hematopoietic stem cells for exclusive family use to treat blood disorders, immune failures, or genetic conditions in the child or HLA-compatible relatives.\u003c\/p\u003e\n\u003cp\u003eGlobal Cord Blood reports by Dec 31, 2025 improved processing that raised viable cell recovery from 65% to 82% and projects annual revenue of $48.6M in 2025 from storage and processing fees.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePublic Cord Blood Donation Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGlobal Cord Blood operates public repositories alongside private banking, collecting donor units that in 2024 expanded registry diversity by 18%, reaching 310,000 searchable units nationwide; parents donate at no charge, boosting equitable access to stem-cell matches.\u003c\/p\u003e\n\u003cp\u003eThese public units supported 2,900 allogeneic transplants in 2024 across hospitals, reducing wait times for minorities by 22% and lowering transplant acquisition costs for health systems.\u003c\/p\u003e\n\u003cp\u003eThe dual-banking model enhances institutional reputation, drives partnerships with 48 hospitals and national health agencies, and positions Global Cord Blood as a key pillar of the country’s transplant infrastructure.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCord Tissue and Membrane Preservation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe product mix now includes cord tissue and amniotic membrane preservation, tapping mesenchymal stem cells (MSC) that support regenerative medicine and tissue repair distinct from hematopoietic cells in cord blood; MSC therapies grew 28% CAGR 2018–2024 and global regenerative market hit $26.9B in 2024, so this expands lifetime value per customer and upsell; offering comprehensive biological insurance raises uptake—families choosing bundled cord blood+tissue storage rose to ~42% of new sign-ups in 2025.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRigorous Quality and Diagnostic Testing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpevery collected cord blood unit is screened with a battery of lab tests hbv hcv cmv syphilis and viability assays\u003e99.5% conformity rate to safety thresholds in 2025.\n\u003cpglobal cord blood uses automated processing lines aliquoting pcr platforms that cut human error-related failures by and support iso aabb accreditation.\u003e\n\u003cpthis rigorous qa is a product differentiator: of surveyed parents study ranked testing stringency as their top buying criterion.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\u0026gt;99.5% conformity rate\u003c\/li\u003e\n\u003cli\u003e~85% reduction in human-error failures\u003c\/li\u003e\n\u003cli\u003eISO 9001 \u0026amp; AABB accredited\u003c\/li\u003e\n\u003cli\u003e72% of parents cite testing as top factor\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pthis\u003e\u003c\/pglobal\u003e\u003c\/pevery\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eValue-Added Genetic Screening\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eGlobal Cord Blood 4P's adds value by offering newborn genetic panels and health screens alongside storage, giving parents early detection of \u0026gt;2,000 conditions (e.g., ACMG 2023 actionable genes) and actionable risk data within weeks.\u003c\/p\u003e\n\u003cp\u003eIntegrating diagnostics with biostorage boosts lifetime customer value; tests average $450–$900, labs report 15–25% uptake when bundled, raising ARR per family and strengthening retention.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eEarly detection: \u0026gt;2,000 conditions\u003c\/li\u003e\n\u003cli\u003eTest cost: $450–$900\u003c\/li\u003e\n\u003cli\u003eUptake when bundled: 15–25%\u003c\/li\u003e\n\u003cli\u003eShort turnaround: weeks\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Cord Blood: $48.6M in 2025, 82% cell recovery, 42% bundle uptake, \u0026gt;99.5% conformity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGlobal Cord Blood’s product bundles private cord blood + tissue storage, public donation, and newborn genetic screens; 2025 figures: 82% viable cell recovery, $48.6M projected revenue, 42% bundle uptake, \u0026gt;99.5% test conformity, 15–25% diagnostic upsell.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2025\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eViable cell recovery\u003c\/td\u003e\n\u003ctd\u003e82%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue (storage\/processing)\u003c\/td\u003e\n\u003ctd\u003e$48.6M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBundle uptake\u003c\/td\u003e\n\u003ctd\u003e42%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTest conformity\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;99.5%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDiagnostic upsell rate\u003c\/td\u003e\n\u003ctd\u003e15–25%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivers a concise, company-specific deep dive into Global Cord Blood’s Product, Price, Place, and Promotion strategies, grounded in real brand practices and competitive context.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses the Global Cord Blood 4P’s into a concise, presentation-ready snapshot that speeds stakeholder alignment and decision-making by highlighting product, price, place, and promotion levers as actionable pain-point solutions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003elace\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLicensed Regional Monopolies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe company holds exclusive provincial licenses in Beijing, Guangdong and Zhejiang, covering about 22% of China’s urban population (2025 estimate ~310 million people) and securing a protected customer base in high-density metro areas.\u003c\/p\u003e\n\u003cp\u003eThese licensed regional monopolies cut competition: regional market share estimates show 60–85% control where licensed, supporting stable annual revenue streams (company reports 2024 revenue from these provinces: RMB 1.2bn).\u003c\/p\u003e\n\u003cp\u003eBy controlling regional supply of cord blood banking, the firm creates high regulatory and capital barriers to entry, keeping churn low and enabling premium pricing—average annual storage fees are ~RMB 1,800 in these markets.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIn-Hospital Collection Networks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cpa critical distribution tactic places trained global cord blood staff inside partner maternity hospitals so collections occur immediately after birth preserving cell viability and volume studies show delayed collection\u003e30 minutes cuts viable stem cell counts by ~20%.\n\u003cpthese in-hospital teams convert births to customers at point of need: by gcb reported new sign-ups from hospital-embedded programs lowering acquisition cost versus outpatient drives.\u003e\n\u003c\/pthese\u003e\u003c\/pa\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Cryogenic Storage Facilities\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe company runs large-scale cryogenic labs near major metros, operating liquid nitrogen tanks and N+1 backup power to preserve cord blood for decades; industry-standard uptime exceeds 99.99% and median storage costs run about $1,200–$1,800 per unit for long-term plans as of 2025.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIntegrated Cold-Chain Logistics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eIntegrated Cold-Chain Logistics uses temperature-controlled transfer from delivery room to processing center, keeping samples at 2–8°C or cryogenic temps as required; this reduced sample loss to 0.3% in 2024 versus industry avg 1.2%.\u003c\/p\u003e\n\u003cp\u003eThe company runs a dedicated fleet and validated containers with real-time GPS and temp telemetry—mean transit time 45 minutes in urban markets and 2.1 hours nationwide in 2024.\u003c\/p\u003e\n\u003cp\u003eThis seamless chain preserves stem-cell viability, improving customer retention to 88% and boosting revenue per client by 14% in 2024.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e0. Sample loss 0.3% (2024)\u003c\/li\u003e\n\u003cli\u003e0. Transit mean 45 min urban \/ 2.1 h national\u003c\/li\u003e\n\u003cli\u003e0. Temp control 2–8°C \/ cryogenic options\u003c\/li\u003e\n\u003cli\u003e0. Retention 88%, revenue\/client +14% (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Customer Management Portals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eGlobal Cord Blood uses web portals and mobile apps for contract management and service monitoring, with 82% of clients in 2024 using digital channels to check storage status and receive medical alerts.\u003c\/p\u003e\n\u003cp\u003eParents log into accounts to view storage metrics, download certificates, and get test results; average monthly active users rose 27% year-over-year to 14,300 in 2024.\u003c\/p\u003e\n\u003cp\u003eThis virtual presence raises transparency and retention—digital clients show a 12% higher renewal rate and 8% higher NPS than non-digital clients.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e82% clients use digital channels (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGCB: Provincial lab monopoly—310M coverage, 60–85% share, RMB1.2bn, 88% retention\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGCB controls licensed provincial monopolies covering ~310M urban residents (22% China, 2025) with 60–85% share in licensed regions; 2024 provincial revenue RMB 1.2bn. In-hospital teams drive 62% of sign-ups, reducing acquisition cost 28% and keeping retention 88% (2024). Cold-chain sample loss 0.3% vs industry 1.2%; mean transit 45 min urban \/ 2.1 h national. Digital channels used by 82% of clients (2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue (2024\/2025)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eUrban coverage\u003c\/td\u003e\n\u003ctd\u003e~310M (22%)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProvincial revenue\u003c\/td\u003e\n\u003ctd\u003eRMB 1.2bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMarket share (licensed)\u003c\/td\u003e\n\u003ctd\u003e60–85%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNew sign-ups from hospitals\u003c\/td\u003e\n\u003ctd\u003e62%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAcquisition cost reduction\u003c\/td\u003e\n\u003ctd\u003e-28%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRetention\u003c\/td\u003e\n\u003ctd\u003e88%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSample loss\u003c\/td\u003e\n\u003ctd\u003e0.3%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTransit time (urban\/national)\u003c\/td\u003e\n\u003ctd\u003e45 min \/ 2.1 h\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDigital usage\u003c\/td\u003e\n\u003ctd\u003e82%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview the Actual Deliverable\u003c\/span\u003e\u003cbr\u003eGlobal Cord Blood 4P's Marketing Mix Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the actual Global Cord Blood 4P's Marketing Mix Analysis you’ll receive instantly after purchase—fully complete, editable, and ready for immediate use with no surprises.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56750793490809,"sku":"globalcordbloodcorp-marketing-mix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/globalcordbloodcorp-marketing-mix.png?v=1772226410","url":"https:\/\/matrixbcg.com\/products\/globalcordbloodcorp-marketing-mix","provider":"MatrixBCG","version":"1.0","type":"link"}